Zhong Jingtao, Sui Runqian, Zi Jie, Wang Anbiao
Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Front Pharmacol. 2025 Feb 17;15:1453835. doi: 10.3389/fphar.2024.1453835. eCollection 2024.
This study aimed to analyze the effects of perioperative morphine and fentanyl use on delirium, length of ICU stay, and in-hospital mortality after cardiac surgery.
This cohort study retrieved the data of 4,596 patients admitted to ICU after cardiac surgery in MIMIC-IV database from 2008 to 2019. The primary outcome was postoperative delirium. The secondary outcomes were length of ICU stay, and in-hospital mortality. To compare the effects of perioperative fentanyl and morphine use on postoperative delirium, length of ICU stay, and in-hospital mortality, univariate, two-way stepwise, as well as multivariable Logistic regression, linear regression, and Cox proportional hazards models was respectively used. Odd ratio (OR), β coefficient, hazard ratio (HR), and respective confidence interval (CI) were calculated. Subgroup analysis was conducted in terms of age, use of extracorporeal circulation, midazolam, dexmedetomidine or surgery type.
In total, the data of 4,596 patients were analyzed including 2,589 morphine user and 2007 fentanyl user. We found that the risk of postoperative delirium was reduced in patients with cardiac surgery undergoing perioperative morphine relative to perioperative fentanyl (OR = 0.62, 95%CI: 0.40-0.96). Perioperative morphine use was negatively correlated with the length of ICU stay in patients with cardiac surgery in comparison to patients with perioperative fentanyl use (β = -0.72, 95%CI: -1.06, -0.39). Relative to patients who had perioperative fentanyl, patients who had perioperative morphine were associated with reduced risk of in-hospital mortality in patients with cardiac surgery after adjusting for respective confounding factors (HR = 0.35, 95%CI: 0.13-0.91).
Perioperative morphine use was related to lower risk of delirium and in-hospital mortality as well as shortened length of ICU stay in these patients. The findings might offer a reference for perioperative anesthesia management in patients receiving cardiac surgery.
本研究旨在分析围手术期使用吗啡和芬太尼对心脏手术后谵妄、重症监护病房(ICU)住院时间及院内死亡率的影响。
这项队列研究检索了2008年至2019年MIMIC-IV数据库中4596例心脏手术后入住ICU患者的数据。主要结局是术后谵妄。次要结局是ICU住院时间和院内死亡率。为比较围手术期使用芬太尼和吗啡对术后谵妄、ICU住院时间和院内死亡率的影响,分别使用单因素、双向逐步以及多变量逻辑回归、线性回归和Cox比例风险模型。计算比值比(OR)、β系数、风险比(HR)及各自的置信区间(CI)。根据年龄、体外循环使用情况、咪达唑仑、右美托咪定或手术类型进行亚组分析。
共分析了4596例患者的数据,其中2589例使用吗啡,2007例使用芬太尼。我们发现,与围手术期使用芬太尼相比,心脏手术患者围手术期使用吗啡术后谵妄风险降低(OR = 0.62,95%CI:0.40 - 0.96)。与围手术期使用芬太尼的患者相比,心脏手术患者围手术期使用吗啡与ICU住院时间呈负相关(β = -0.72,95%CI:-1.06,-0.39)。在调整各自的混杂因素后,与围手术期使用芬太尼的患者相比,围手术期使用吗啡的心脏手术患者院内死亡风险降低(HR = 0.35,95%CI:0.13 - 0.91)。
围手术期使用吗啡与这些患者谵妄风险降低、院内死亡率降低以及ICU住院时间缩短有关。这些发现可能为接受心脏手术患者的围手术期麻醉管理提供参考。